Funder
Korea Ministry of Food and Drug Safety
Ministry of Education
Automation and Systems Research Institute (ASRI), Seoul National University
Institute of Information & communications Technology Planning & Evaluation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference37 articles.
1. WHO. The importance of pharmacovigilance. World Health Organization; 2002.
2. Huang YL, Moon J, Segal JB. A comparison of active adverse event surveillance systems worldwide. Drug Saf. 2014;37(8):581–96.
3. Alomar M, Tawfiq AM, Hassan N, Palaian S. Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future. Ther Adv Drug Saf. 2020;11:2042098620938595.
4. KIDS. Pharmacovigillance—statistics on reported ICSRs. 2022 [cited 2022 6 May]. Available from: https://www.drugsafe.or.kr/iwt/ds/en/report/EgovICSRStatistics.do.
5. Oh I-S, Baek Y-H, Kim H-J, Lee M, Shin J-Y. Differential completeness of spontaneous adverse event reports among hospitals/clinics, pharmacies, consumers, and pharmaceutical companies in South Korea. PLoS ONE. 2019;14(2): e0212336.